Biotechnology

Clinical trial patient recruitment and retention has the greatest impact on clinical trial costs, according to 'Streamlining Clinical Trials' , a new study by pharmaceutical business intelligence leader Cutting Edge Information. Not only does patient rec

Company prepares to launch Moxatag, the first and only FDA-approved once-daily amoxicillin, in the first quarter of 2009

Arete Therapeutics Inc., a privately-held biotechnology company developing first-in-class soluble epoxide hydrolase inhibitors, today announced that it has closed the final tranche of its Series A financing. Frazier Healthcare Ventures and Alta Partners

Chelsea Therapeutics International, Ltd. has completed patient enrollment in its Phase II trial of Droxidopa, an orally active synthetic precursor of norepinephrine, in patients with intradialytic hypotension .

Theravance, Inc. today announced that NASDAQ halted trading of Theravance common stock this morning, November 19, 2008. The Anti-Infective Drugs Advisory Committee to the U.S. Food and Drug Administration meets today to review and discuss the company's N

TORONTO, Nov. 19 /PRNewswire-FirstCall/ - GeneNews Limited , a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced the formation of a Canadian Colorectal Cancer

Isogen, a contract development and manufacturing organization for sterile filling, today announced the first phase launch of its contract facility inDelaware. Isogen was founded to specifically address the process, facility and capacity problems commonly

CommonHealth , the world's leading healthcare-communications network and a WPP company, today announced one promotion and four new hires.